The following is a summary of “Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients ...

GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB-205), a novel CD5 CAR-NK cell therapy. This "first ...

Five years ago, the TV industry rose to the challenge of staying on air as the pandemic dawned. Insiders look back on Variety ...

A PSA test checks the level of prostate specific antigen (PSA) in blood and high levels may be a sign of a prostate condition ...

Nkarta (NASDAQ:NKTX – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($0.39) per ...

This study developed a highly accurate HLA imputation reference panel tailored to the Han Chinese population, uncovering ...

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.

The following is a summary of “Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With ...

This kind of behavior, once an exception, has now become the norm. We all reveal TMI, even when it comes to health care. And ...

The "Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. The Chimeric Antigen Receptor T-Cell Therapy (CAR-T) ...